Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario
Suleman A, Ante Z, Liu N, Crump M, Chan KKW, Cheung MC, Prica A. Blood Neoplasia. 2026; 3(2): 100184. Epub 19 Nov 2025.
Publications
Thyroid cancer treatment among adolescents and young adult women and reproductive outcomes: a population-based cohort study
Imsirovic H, Richardson H, Shellenberger J, Velez MP. Hum Reprod Open. 2025; 2025(4): hoaf070.
A population-based matched cohort study of extra-digestive cancer incidence and mortality in individuals with and without inflammatory bowel disease
Murthy SK, Ahmed F, Pugliese M, Taljaard M, Tandon P, Matthews P, Kaplan GG, Coward S, Bernstein CN, Benchimol EI, Kuenzig ME, Targownik LE, Singh H; Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC). Aliment Pharmacol Ther. 2025; Nov 11 [Epub ahead of print].
Development and validation of EsoTIME, a prognostication tool for resected esophageal and gastroesophageal cancer
Harrison LD, Gupta V, Yuen M, Coburn NG, Pugliese M, Ekuma O, Derksen S, Compton C, Boyes R, Davis L, Decker K, Kidane B, Ringash J, Hsu AT, Mahar A; Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO) Group. Ann Surg Oncol. 2026; 33(2):955-966. Epub 2025 Oct 25.
Physician payment models and preventive cancer screening: a population-based retrospective cohort analysis from Ontario, Canada
Bai Y, Devlin RA, Habbous S, Jaakkimainen L, Sarma S. Fam Pract. 2025; 42(6):cmaf076.
Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis
Liu B, Parmar A, Luo J, Dai WF, Chan KKW. Eur J Health Econ. 2025; Oct 8 [Epub ahead of print].
Contemporary incidence and survival of lung neuroendocrine neoplasms
Hallet J, Rousseau M, Wakeam E, Myrehaug S, Meloche-Dumas L, Gombay A, Chan W, Singh S. JAMA Netw Open. 2025; 8(10):e2535125.
Impact of immigration status on survival among stage 1 and 2 HER2-positive and triple-negative breast cancer in Ontario, Canada
Fatiregun O, Sutradhar R, Podolsky S, Eisen A, Paszat L, Rakovitch E. Cancer Med. 2025; 14(19):e71288.
Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors-related AKI
Blanchette P, Reid J, Richard L, Shariff SZ, Raphael J, Earle CC, Garg AX, Kitchlu A. Nephrol Dial Transplant. 2025; gfaf191. Epub 2025 Sep 27.
Development of machine learning systems to predict cancer-related symptoms with validation across a health care system
Yuan B, Kabir M, He JC, Li Y, Grant B, Narine S, Welch M, Podolsky S, Liu N, Ajaj R, Zhan LJ, Fawzy A, Xu J, Zhang Y, Yu V, Xu W, Krishnan RG, Gallinger S, Chan KKW, Krzyzanowska MK, Truong T, Liu G, Grant RC. JCO Clin Cancer Inform. 2025; 9:e2500073. Epub 2025 Sep 25.